Guanglin Cui
Impact in
- Immunology top 2%
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cytokine Signaling Pathways and Interactions
Papers in
- Immunology 47
- IL-33, ST2, and ILC Pathways 18
- Psoriasis: Treatment and Pathogenesis 10
- Genetics 31
- Inflammatory Bowel Disease 19
- Genetic Associations and Epidemiology 9
- Co-authors
- Rasmus Goll (26 shared papers)Jon Florholmen (23 shared papers)Aping Yuan (22 shared papers)Trine Olsen (13 shared papers)Timothy C. Wang (10 shared papers)Dao Wen Wang (33 shared papers)Shigeo Takaishi (6 shared papers)James G. Fox (5 shared papers)
- Journals
- Scandinavian Journal of Gastroenterology (8 papers)Cancer Immunology Immunotherapy (4 papers)Pathology & Oncology Research (4 papers)PLoS ONE (3 papers)Biomedicine & Pharmacotherapy (3 papers)
- Partner nations
- ChinaNorwayUnited States
In The Last Decade
Guanglin Cui
119 papers receiving 3.8k citations
Guanglin Cui's Hit Papers
Peers
Comparison fields: 5 of 132
- Immunology 1.5k
- Oncology 1.0k
- Gastroenterology 175
- Genetics 744
- Cancer Research 353
Countries citing papers authored by Guanglin Cui
This map shows the geographic impact of Guanglin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanglin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanglin Cui more than expected).
Fields of papers citing papers by Guanglin Cui
This network shows the impact of papers produced by Guanglin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanglin Cui. The network helps show where Guanglin Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Guanglin Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice Hit paper breakdown → | 2008 | 659 |
| 2 | 2007 | 122 | |
| 3 | 2011 | 113 | |
| 4 | 2012 | 92 | |
| 5 | 2018 | 91 | |
| 6 | 2014 | 86 | |
| 7 | 2005 | 86 | |
| 8 | 2018 | 74 | |
| 9 | 2012 | 68 | |
| 10 | 2009 | 66 | |
| 11 | 2007 | 63 | |
| 12 | 2012 | 62 | |
| 13 | 2021 | 62 | |
| 14 | 2006 | 57 | |
| 15 | 2003 | 57 | |
| 16 | 2019 | 55 | |
| 17 | 2014 | 55 | |
| 18 | 2018 | 54 | |
| 19 | 2009 | 51 | |
| 20 | 2001 | 50 |
About Guanglin Cui
Guanglin Cui is a scholar working on Immunology, Genetics, Oncology, Surgery and Molecular Biology, having authored 126 papers that have together received 3.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (19 papers), IL-33, ST2, and ILC Pathways (18 papers), Cancer Immunotherapy and Biomarkers (16 papers), Helicobacter pylori-related gastroenterology studies (13 papers), Viral Infections and Immunology Research (11 papers), Microscopic Colitis (10 papers), Psoriasis: Treatment and Pathogenesis (10 papers) and Genetic Associations and Epidemiology (9 papers). The work is most often cited by research in Immunology (1.5k citations), Oncology (1.0k citations), Gastroenterology (175 citations), Genetics (744 citations) and Cancer Research (353 citations). Guanglin Cui has collaborated with scholars based in China, Norway and United States. Frequent co-authors include Rasmus Goll, Jon Florholmen, Aping Yuan, Trine Olsen, Timothy C. Wang, Dao Wen Wang, Shigeo Takaishi, James G. Fox, Kelly S. Betz and Olle Björkdahl. Their work appears in journals such as Scandinavian Journal of Gastroenterology, Cancer Immunology Immunotherapy, Pathology & Oncology Research, PLoS ONE and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.